ACHV (ACHV) Stock Price & Analysis
ACHV (ACHV) rose 2.17% to USD 8.49 as of September 8, 2026 at 09:04 UTC, according to Nexqual real-time market data.
ACHV last closed at USD 8.49; the session ranged USD 8.11–8.55 on volume of 886,366 shares. Market capitalization is —, with a 52-week range of USD 2.62–8.64 (NCM). Source: Nexqual, September 8, 2026 at 09:04 UTC.
Key Statistics (as of September 8, 2026 at 09:04 UTC)
| Price | USD 8.49 |
|---|---|
| Change | ▲ 2.17% (up) |
| Previous Close | USD 8.49 |
| Open | USD 8.49 |
| Day Range | USD 8.11 – 8.55 |
| 52-Week Range | USD 2.62 – 8.64 |
| Volume | 886,366 shares |
| Market Cap | — |
| Exchange | NCM |
Technical Analysis (ACHV)
Nexqual's technical model rates ACHV "BUY" based on 5 bullish and 1 bearish signals across 128 daily candles, as of September 8, 2026 at 09:04 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 66.89 (neutral) |
| vs SMA50 | Above (USD 6.92) |
| MACD | 0.47 (positive) |
From ACHV's Latest SEC 10-K Filing (filed 2026-03-24)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| AKTX | Akari Therapeutics Plc | USD 11.47 | ▲ 13% |
| XBIO | Xenetic Biosciences, Inc. | USD 4.67 | ▲ 9.88% |
| DARE | Dare Bioscience, Inc. | USD 0.72 | ▼ 2.57% |
| PRPO | Precipio, Inc. | USD 27.4 | ▼ 0.36% |
| ADIL | Adial Pharmaceuticals, Inc | USD 7.12 | ▲ 12.66% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 09:04 UTC. This page is informational and not investment advice.